Skip to content
Pharma Observatory a Scientist.com platform

Organization (Hospital)

First People's Hospital of Chenzhou

ClinicalTrials.gov lists First People's Hospital of Chenzhou as lead sponsor of 12 trials. It has 1 active development program and 2 approved assets.

CN Hospital
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

6 0 2012 2026

Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

2026 is partial: 3 registered with a 2026 start date. The dashed outline is the pace from the 3 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 3.4 trial starts a year over the five years to September, under the 5 a year the method needs.

This page covers First People's Hospital of Chenzhou: 12 lead-sponsored trials and 0 legal-entity registrations.

Get the First People's Hospital of Chenzhou report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Disease areas (31)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Leukemia, Myeloid, Acute 5
Inflammation 3
Myelodysplastic Syndromes 3
Sepsis 3
Lung Neoplasms 2

Showing 5 of 31 disease areas.

Start your 14-day trial Email me all 31 disease areas as a PDF

Trials by start year as sponsor or collaborator (14)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Show the table of trials by start year as sponsor or collaborator
Trials by start year as sponsor or collaborator
Year Trials started
2026 (partial year) 3
2025 4
2024 2
2023 2
2022 6
2021 3
2020 2
2019 1
2018 3
2016 2

Showing 10 of 14 years.

Start your 14-day trial Email me all 14 years as a PDF

Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

Active development programs (1)

Active development programs
Drug Disease area Max phase Trials
conventional analgesia Pancreatitis Not reported 1

Approved assets (2)

Shown in this order: max phase first.

Approved assets
Drug Trials
DEXMEDETOMIDINE 1
(R,S)-ketamine (Pilot I) 1

Journals published in (21)

Shown in this order: most published in first.

Journals published in
Journal Publications
The Lancet. Haematology 3
Bone marrow transplantation 2
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2
BMC medicine 1
BMC nephrology 1

Showing 5 of 21 journals.

Start your 14-day trial Email me all 21 journals as a PDF

Organization relationships (67)

Shown in this order: most evidence first.

Organization relationships
Related organization Relationship Evidence
Nanfang Hospital, Southern Medical University Co sponsors trial with 10
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Co sponsors trial with 7
Xiangya Hospital Central South University Co sponsors trial with 5
Institute of Hematology & Blood Diseases Hospital, China Co sponsors trial with 4
Shenzhen Second People's Hospital Co sponsors trial with 3

Showing 5 of 67 relationships.

Start your 14-day trial Email me the first 50 relationships as a PDF

Latest dated events (33)

Shown in this order: newest first.

Latest dated events
Date Event Source
2026-08-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-02-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-01-02 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2025-09-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2025-06-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Showing 5 of 33 events.

Start your 14-day trial Email me all 33 events as a PDF

Biomarker capability evidence (26)

Shown in this order: tier desc, then gene symbol.

Biomarker capability evidence
Gene Role Evidence
ALB Trial collaborator Named in trial inclusion criteria
ALB Trial collaborator Named in trial inclusion criteria
ALK Trial collaborator Named in trial inclusion criteria
ASL Trial collaborator Named in trial inclusion criteria
CR1 Trial collaborator Named in trial inclusion criteria

Showing 5 of 26 evidence rows.

Start your 14-day trial Email me all 26 evidence rows as a PDF

Biomarkers this organization publishes on (31)

Shown in this order: most publications first.

Biomarkers this organization publishes on
Biomarker Publications
GGT1 2
ADRA2B 1
ALK 1
APOA1 1
APOB 1

Showing 5 of 31 biomarkers.

Start your 14-day trial Email me all 31 biomarkers as a PDF

Not on this page

Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, sponsor delivery record, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, and clia clinical laboratory certificates.